Given CHIP’s well-established role in atherosclerosis and large-vessel cardiovascular disease, it is reasonable to hypothesize that similar mechanisms extend to the cerebral microvasculature, potentially promoting small vessel pathology, white matter damage, and cognitive decline. The gene discussed is STUB1; the disease is cardiovascular disorder.